Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 13,982 shares at $288.92 ($4.0M) on 2023-02-27, disclosed to the SEC on 2023-02-28.
Seasonal sale ($4.0M) by EVP, COO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $289.12 | 4,714 | $1.4M | 33.9% |
| 2 | $287.16 | 3,834 | $1.1M | 27.3% |
| 3 | $287.16 | 3,834 | $1.1M | 27.3% |
| 4 | $287.59 | 400 | $115K | 2.9% |
| 5 | $287.59 | 400 | $115K | 2.9% |
| 6 | $288.92 | 800 |
| $231K |
| 5.7% |
| Total | $287.95 avg | 13,982 | $4.0M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |